Trial Profile
Prospective study of Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration in Japanese Patients
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 21 Jun 2017 New trial record